SUBSCRIBE
SUBSCRIBE

Phase I

Drug Development
Biopharma Update on the Novel Coronavirus: June 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 22, 2020.
June 22, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Clinical Catch-Up: June 15-19
It was a busy week for clinical trial announcements. Here’s a look.
June 19, 2020
 · 
12 min read
 · 
Mark Terry
Drug Development
Clinical Trials Are Starting Back Up, but Some Future Approvals May be Delayed
According to a BioPharma Dive report, since March, more than 100 biopharma companies announced their clinical trials were disrupted in some way because of the pandemic.
June 19, 2020
 · 
3 min read
 · 
Mark Terry
Drug Development
Biopharma Update on the Novel Coronavirus: June 19
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 19, 2020.
June 18, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Pfizer and Sangamo Release Updated Gene Therapy Data in Hemophilia A
Pfizer and Sangamo Therapeutics released follow-up data from its Phase I/II Alta study in hemophilia A that showed an investigational gene therapy treatment provided blood-clotting activity levels for more than one year.
June 18, 2020
 · 
3 min read
 · 
Alex Keown
BioMarin HQ/courtesy of BioMarin
Drug Development
BioMarin Shares Additional Promising Phase I/II Data on Hemophilia A Treatment
BioMarin Pharmaceutical released new data today from its previously reported four-year update of the open-label Phase I/II study of valoctocogene roxaparvovec.
June 17, 2020
 · 
3 min read
 · 
Krystle Vermes
Drug Development
Biopharma Update on the Novel Coronavirus: June 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 17, 2020.
June 16, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Study: Pfizer’s Experimental Diabetes Drug Robustly Reduces Weight and Glucose
Data presented at the virtual American Diabetes Association meeting has Pfizer excited about the promise of its GLP-1R Agonist PF-06882961.
June 16, 2020
 · 
2 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: June 15
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 15, 2020.
June 15, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Sinovac Biotech’s COVID-19 Vaccine Shows Positive Early Results
Sinovac Biotech announced positive early data from a Phase I/II clinical trial of its COVID-19 vaccine, CoronaVac. The vaccine showed both favorable immunogenicity and safety.
June 15, 2020
 · 
3 min read
 · 
Mark Terry
Load More
PRESS RELEASES
Drug Development
Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study
March 20, 2024
 · 
5 min read
Drug Development
Inhalon Biopharma Announces Positive Results from Study Demonstrating Superior Safety and Efficacy of its Inhaled Antibody Platform Over Systemic Dosing
March 20, 2024
 · 
3 min read
Drug Development
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
March 20, 2024
 · 
4 min read
Drug Development
ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease
March 20, 2024
 · 
8 min read
Drug Development
DepYmed Receives Clearance from U.S. Food and Drug Administration to Initiate Phase 1 Clinical Trial for DPM-1003 for the Treatment of Rett Syndrome
March 19, 2024
 · 
3 min read
Drug Development
YourChoice Therapeutics Scientific Advisory Board member updates phase 1a study for male birth control candidate at ACS Spring 24
March 19, 2024
 · 
3 min read
Drug Development
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial
March 19, 2024
 · 
6 min read
Drug Development
Recce Pharmaceuticals Completes Dosing Cohort in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis
March 19, 2024
 · 
3 min read
Drug Development
Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria
March 19, 2024
 · 
6 min read
Drug Development
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
March 18, 2024
 · 
7 min read
Drug Development
Inside Information: Additional Positive Data from the Phase 1 Part of the BEXMAB Study in Both Higher-Risk HMA-Failed MDS and r/r AML
March 18, 2024
 · 
8 min read
Drug Development
AliveGen Announces Successful Completion of Phase 1b Multiple-Ascending Dose Clinical Trial for ALG-801
March 18, 2024
 · 
2 min read
Drug Development
Lantern Pharma Announces Initial Patients Dosed in First-In-Human Clinical Trial for AI-Guided Drug-Candidate, LP-284
March 15, 2024
 · 
8 min read
Drug Development
New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia
March 15, 2024
 · 
7 min read
Drug Development
Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors
March 14, 2024
 · 
4 min read
Drug Development
Cantargia Presents New Human Data Further Supporting CAN10 in the Treatment of Systemic Sclerosis
March 14, 2024
 · 
5 min read
Drug Development
Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer
March 14, 2024
 · 
8 min read
Drug Development
Gynica announces First-in-Human Clinical Trial of Novel IntraVag© Treatment for Endometriosis
March 14, 2024
 · 
3 min read
Drug Development
Recce Pharmaceuticals Doses Next Cohort in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis
March 14, 2024
 · 
3 min read
Drug Development
Immuneering Announces Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors
March 14, 2024
 · 
11 min read
Load More